argenx SE (ARGX) PT Raised to $64 at Wedbush on 'Myasthenia Gravis Data Impressive'
Tweet Send to a Friend
Wedbush raised its price target on argenx SE (NASDAQ: ARGX) to $64.00 (from $41.00) while maintaining a Outperform rating, following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
